These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2707888)

  • 21. Honeybee and wasp venom allergy: Sensitization and immunotherapy.
    Adib-Tezer H; Bayerl C
    J Dtsch Dermatol Ges; 2018 Oct; 16(10):1228-1247. PubMed ID: 30300499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibody response pattern (specific IgE and IgG) of insect sting allergic patients in immunotherapy with venom preparations].
    Wüthrich B; Arrendal H; Lanner A
    Schweiz Med Wochenschr; 1981 Nov; 111(46):1756-65. PubMed ID: 7313646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of hyposensitization with bee and wasp venom].
    Adolph J; Dehnert I; Fischer JF; Wenz W
    Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of specific IgE and IgG4 measurements in the follow-up of a hymenoptera venom immunotherapy treatment: apropos of 82 cases].
    Sonneville A; Loustanau O; Tahar HA; Menelet I
    Allerg Immunol (Paris); 2000 Jan; 32(1):20-5. PubMed ID: 10723532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and immunologic follow-up of patients who stop venom immunotherapy.
    Keating MU; Kagey-Sobotka A; Hamilton RG; Yunginger JW
    J Allergy Clin Immunol; 1991 Sep; 88(3 Pt 1):339-48. PubMed ID: 1890261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy.
    Urbanek R; Kemeny DM; Richards D
    Clin Allergy; 1986 Jul; 16(4):317-22. PubMed ID: 3742787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety.
    Müller U; Helbling A; Berchtold E
    J Allergy Clin Immunol; 1992 Feb; 89(2):529-35. PubMed ID: 1740583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of an in-hospital insect sting challenge as a criterion for application or omission of venom immunotherapy.
    Blaauw PJ; Smithuis OL; Elbers AR
    J Allergy Clin Immunol; 1996 Jul; 98(1):39-47. PubMed ID: 8765816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bee and wasp venom allergy in Turkey.
    Kalyoncu AF; Demir AU; Ozcan U; Ozkuyumcu C; Sahin AA; Bariş YI
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):408-12. PubMed ID: 9109709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy.
    Golden DB; Meyers DA; Kagey-Sobotka A; Valentine MD; Lichtenstein LM
    J Allergy Clin Immunol; 1982 Jun; 69(6):489-93. PubMed ID: 7076990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme-like immunosorbent assay (ELISA) for immunoglobulin G antibodies against insect venoms.
    Grant JA; Goldblum RM; Rahr R; Thueson DO; Farnam J; Gillaspy J
    J Allergy Clin Immunol; 1981 Aug; 68(2):112-8. PubMed ID: 6166648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double sensitization to honeybee and wasp venom: immunotherapy with one or with both venoms? Value of FEIA inhibition for the identification of the cross-reacting ige antibodies in double-sensitized patients to honeybee and wasp venom.
    Straumann F; Bucher C; Wüthrich B
    Int Arch Allergy Immunol; 2000 Nov; 123(3):268-74. PubMed ID: 11112864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of passive and active immunization in honeybee venom immunotherapy.
    Bousquet J; Fontez A; Aznar R; Robinet-Levy M; Michel FB
    J Allergy Clin Immunol; 1987 Jun; 79(6):947-54. PubMed ID: 3584749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late-onset allergic reactions, including serum sickness, after insect stings.
    Reisman RE; Livingston A
    J Allergy Clin Immunol; 1989 Sep; 84(3):331-7. PubMed ID: 2778239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgE antibodies to bee venom, phospholipase A, melittin and wasp venom.
    Jarisch R; Yman L; Boltz A; Sandor I; Janitsch A
    Clin Allergy; 1979 Sep; 9(5):535-41. PubMed ID: 498494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stinging insect allergy: natural history and modification with venom immunotherapy.
    Reisman RE; Dvorin DJ; Randolph CC; Georgitis JW
    J Allergy Clin Immunol; 1985 Jun; 75(6):735-40. PubMed ID: 4008803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy with wasp venom is accompanied by wide-ranging immune responses that need further exploration.
    Brasch J; Maidusch T
    Acta Derm Venereol; 2009; 89(5):466-9. PubMed ID: 19734970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy of venom immunotherapy.
    Hafner T; DuBuske L; Kosnik M
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):162-5. PubMed ID: 18320918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined active and passive immunotherapy in honeybee-sting allergy.
    Müller UR; Morris T; Bischof M; Friedli H; Skarvil F
    J Allergy Clin Immunol; 1986 Jul; 78(1 Pt 1):115-22. PubMed ID: 3722631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discontinuation of yellow jacket venom immunotherapy: follow-up of 75 patients by means of deliberate sting challenge.
    van Halteren HK; van der Linden PW; Burgers JA; Bartelink AK
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):767-70. PubMed ID: 9438484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.